Bridget E. Bunner

Array ( [id] => 1279899 [patent_doc_number] => 06646113 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Nucleic acid molecule encoding human survival of motor neuron-interacting protein 1 (SIP1) deletion mutants' [patent_app_type] => B1 [patent_app_number] => 09/399081 [patent_app_country] => US [patent_app_date] => 1999-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 126 [patent_no_of_words] => 68527 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/646/06646113.pdf [firstpage_image] =>[orig_patent_app_number] => 09399081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745094 [patent_doc_number] => 20030022277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'HUMAN NEUROPEPTIDE RECEPTOR' [patent_app_type] => new [patent_app_number] => 09/393696 [patent_app_country] => US [patent_app_date] => 1999-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 103598 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022277.pdf [firstpage_image] =>[orig_patent_app_number] => 09393696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202574 [patent_doc_number] => 06720175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Nucleic acid molecule encoding homer 1B protein' [patent_app_type] => B1 [patent_app_number] => 09/377285 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 63 [patent_no_of_words] => 75224 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720175.pdf [firstpage_image] =>[orig_patent_app_number] => 09377285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710273 [patent_doc_number] => 07056694 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-06 [patent_title] => 'DNA encoding peripheral-type benzodiazipine receptor associated protein 7 and applications or methods of use' [patent_app_type] => utility [patent_app_number] => 09/762594 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13751 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056694.pdf [firstpage_image] =>[orig_patent_app_number] => 09762594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 933885 [patent_doc_number] => 06977080 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-20 [patent_title] => 'Intrapericardial botulinum toxin treatment for bradycardia' [patent_app_type] => utility [patent_app_number] => 09/371354 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9736 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977080.pdf [firstpage_image] =>[orig_patent_app_number] => 09371354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1222835 [patent_doc_number] => 06699466 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'IL-16 antagonist peptides and DNA encoding the peptides' [patent_app_type] => B1 [patent_app_number] => 09/368630 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10778 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699466.pdf [firstpage_image] =>[orig_patent_app_number] => 09368630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020854 [patent_doc_number] => 06887477 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 09/762188 [patent_app_country] => US [patent_app_date] => 1999-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 9725 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887477.pdf [firstpage_image] =>[orig_patent_app_number] => 09762188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460577 [patent_doc_number] => 06392019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Antibodies specific for EGF motif proteins' [patent_app_type] => B1 [patent_app_number] => 09/363316 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 32682 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/392/06392019.pdf [firstpage_image] =>[orig_patent_app_number] => 09363316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486806 [patent_doc_number] => 06428781 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Composition of an endogenous insulin-like growth factor-II derivative' [patent_app_type] => B1 [patent_app_number] => 09/331851 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 12854 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428781.pdf [firstpage_image] =>[orig_patent_app_number] => 09331851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730125 [patent_doc_number] => 20030186315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'ADMINISTRATION OF AN AGENT WHICH DECREASES PROCESSING OF AMYLOID PRECURSOR PROTEIN' [patent_app_type] => new [patent_app_number] => 09/297877 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5970 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186315.pdf [firstpage_image] =>[orig_patent_app_number] => 09297877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357891 [patent_doc_number] => 06573095 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Polynucleotides isolated from skin cells' [patent_app_type] => B1 [patent_app_number] => 09/312283 [patent_app_country] => US [patent_app_date] => 1999-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 80070 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573095.pdf [firstpage_image] =>[orig_patent_app_number] => 09312283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1205133 [patent_doc_number] => 06716576 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Method of assaying Neutrokine- mRNA level' [patent_app_type] => B1 [patent_app_number] => 09/255794 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 78217 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716576.pdf [firstpage_image] =>[orig_patent_app_number] => 09255794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1592733 [patent_doc_number] => 06383480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells' [patent_app_type] => B1 [patent_app_number] => 09/214569 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6097 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383480.pdf [firstpage_image] =>[orig_patent_app_number] => 09214569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071566 [patent_doc_number] => 06841147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-11 [patent_title] => 'Stem cell factor compositions' [patent_app_type] => utility [patent_app_number] => 09/224683 [patent_app_country] => US [patent_app_date] => 1998-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 99 [patent_no_of_words] => 50986 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841147.pdf [firstpage_image] =>[orig_patent_app_number] => 09224683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040313 [patent_doc_number] => 06869609 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => 'Method for treatment of renal failure and occlusive lesion of blood vessels by administration of hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 09/555629 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 5067 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869609.pdf [firstpage_image] =>[orig_patent_app_number] => 09555629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1085538 [patent_doc_number] => 06830882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-14 [patent_title] => 'Method of testing compounds for regulation of transcription of peroxisome proliferator activated receptorgamma' [patent_app_type] => B1 [patent_app_number] => 09/155252 [patent_app_country] => US [patent_app_date] => 1998-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8498 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/830/06830882.pdf [firstpage_image] =>[orig_patent_app_number] => 09155252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463195 [patent_doc_number] => 06350856 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Cytokine suppressive anti-inflammatory drug binding protein' [patent_app_type] => B1 [patent_app_number] => 09/047288 [patent_app_country] => US [patent_app_date] => 1998-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 10349 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350856.pdf [firstpage_image] =>[orig_patent_app_number] => 09047288 [rel_patent_id] =>[rel_patent_doc_number] =>)